Utility of Alternate, Noncentromeric Chromosome 17 Reference Probe for Human Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization Testing in Breast Cancer Cases

MLA

Asawari Patil, et al. “Utility of Alternate, Noncentromeric Chromosome 17 Reference Probe for Human Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization Testing in Breast Cancer Cases.” Archives of Pathology & Laboratory Medicine, vol. 142, Jan. 2018, pp. 626–33. EBSCOhost, https://doi.org/10.5858/arpa.2017-0252-oa.

APA

Asawari Patil, Trupti Pai, Omshree Shetty, Angad Singh, Tanuja Shet, & Sangeeta B. Desai. (2018). Utility of Alternate, Noncentromeric Chromosome 17 Reference Probe for Human Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization Testing in Breast Cancer Cases. Archives of Pathology & Laboratory Medicine, 142, 626–633. https://doi.org/10.5858/arpa.2017-0252-oa

Chicago

Asawari Patil, Trupti Pai, Omshree Shetty, Angad Singh, Tanuja Shet, and Sangeeta B. Desai. 2018. “Utility of Alternate, Noncentromeric Chromosome 17 Reference Probe for Human Epidermal Growth Factor Receptor Fluorescence In Situ Hybridization Testing in Breast Cancer Cases.” Archives of Pathology & Laboratory Medicine 142 (January): 626–33. doi:10.5858/arpa.2017-0252-oa.